#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	19698	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2036	950.1	0	.	n	.	0	A293G	SNP	293	293	A	509	509	G	1012	G,A	506,474	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	19698	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2036	950.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1400	1400	C	1036	C	1009	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	35470	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3495	1003.2	0	.	n	.	0	T665C	SNP	665	665	T	945	945	C	1084	C,T	1047,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	35470	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3495	1003.2	0	.	n	.	0	T695C	SNP	695	695	T	975	975	C	1103	C	1073	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	35470	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3495	1003.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1617	1617	A	1199	A,G	1170,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	35470	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3495	1003.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2251	2251	C	1070	C,T,A	1017,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	35470	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3495	1003.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2325	2325	A	1085	A	1055	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	35470	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3495	1003.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2877	2877	C	1076	C,G	1047,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2356	folP	855	855	100.0	folP.l15.c4.ctg.1	1492	155.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1002	1004	AGC	242;242;242	A;G;C	233;233;232	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6356	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3429	183.4	1	SNP	p	S91F	1	.	.	271	273	TTC	632	634	TTC	204;203;204	T;T;C	195;194;194	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6356	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3429	183.4	1	SNP	p	G95N	0	.	.	283	285	GGC	644	646	GGC	196;194;192	G;G;C	187;183;185	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6356	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3429	183.4	1	SNP	p	D95G	1	.	.	283	285	GGC	644	646	GGC	196;194;192	G;G;C	187;183;185	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	2144	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1429	148.1	1	SNP	p	G45D	0	.	.	133	135	GGC	520	522	GGC	228;228;226	G;G;C	227;227;225	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1104	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	965	112.5	0	.	n	.	0	A197.	DEL	197	197	A	534	534	A	230	A	222	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	6220	parC	2304	2304	99.96	parC.l15.c4.ctg.1	2867	214.2	0	.	p	.	0	A512T	NONSYN	1534	1536	GCC	1744	1746	ACC	256;254;254	A;C;C	228;244;240	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	6220	parC	2304	2304	99.96	parC.l15.c4.ctg.1	2867	214.2	1	SNP	p	D86N	0	.	.	256	258	GAC	466	468	GAC	261;260;258	G;A;C	259;252;255	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	6220	parC	2304	2304	99.96	parC.l15.c4.ctg.1	2867	214.2	1	SNP	p	R87W	0	.	.	259	261	CGT	469	471	CGT	256;256;255	C;G;T,A,C	254;251;246,1,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	6220	parC	2304	2304	99.96	parC.l15.c4.ctg.1	2867	214.2	1	SNP	p	R87I	0	.	.	259	261	CGT	469	471	CGT	256;256;255	C;G;T,A,C	254;251;246,1,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	6220	parC	2304	2304	99.96	parC.l15.c4.ctg.1	2867	214.2	1	SNP	p	S87R	1	.	.	259	261	CGT	469	471	CGT	256;256;255	C;G;T,A,C	254;251;246,1,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	539	6220	parC	2304	2304	99.96	parC.l15.c4.ctg.1	2867	214.2	1	SNP	p	S88P	0	.	.	262	264	TCC	472	474	TCC	255;258;256	T;C;C	253;251;249	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5204	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2679	192.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1503	1505	GGC	241;240;236	G;G;C	233;233;226	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4936	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2382	204.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1210	1212	GCA	233;234;235	G;C;A	229;224;232	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4936	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2382	204.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1213	1215	ATC	235;235;238	A;T;C,A	230;229;230,1	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4936	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2382	204.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1225	1227	GTG	239;239;244	G;T;G	231;228;233	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4936	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2382	204.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1225	1227	GTG	239;239;244	G;T;G	231;228;233	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4936	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2382	204.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1729	1731	ACC	250;251;252	A;C;C	235;244;243	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4936	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2382	204.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1783	1785	GCG	244;242;242	G;C,G;G	226;210,1;227	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4936	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2382	204.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1783	1785	GCG	244;242;242	G;C,G;G	226;210,1;227	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4936	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2382	204.1	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1906	1908	AGC	204;202;202	A,G;G;C,T	196,1;196;197,1	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4936	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2382	204.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1915	1917	GGC	205;205;203	G,A;G;C	201,1;202;199	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4936	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2382	204.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1933	1935	CCG	161;166;163	C,G;C,G;G,GGC	140,4;145,1;139,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	7534	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3133	237.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1678	1680	CCG	249;251;253	C;C,A;G,A	223;235,1;234,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2770	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1820	149.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	577	577	C	212	C	200	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3646	porB1b	1041	1041	96.66	porB1b.l6.c4.ctg.1	1518	236.6	0	.	p	.	0	E48G	NONSYN	142	144	GAA	389	391	GGA	316;317;318	G;G;A	305;307;306	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3646	porB1b	1041	1041	96.66	porB1b.l6.c4.ctg.1	1518	236.6	0	.	p	.	0	T87A	NONSYN	259	261	ACT	506	508	GCT	308;309;310	G,C,A;C;T	296,2,1;302;302	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3646	porB1b	1041	1041	96.66	porB1b.l6.c4.ctg.1	1518	236.6	0	.	p	.	0	T89S	NONSYN	265	267	ACC	512	514	AGC	311;309;315	A;G;C,G	300;302;303,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3646	porB1b	1041	1041	96.66	porB1b.l6.c4.ctg.1	1518	236.6	0	.	p	.	0	K120D	NONSYN	358	360	AAG	605	607	GAC	285;287;288	G,A;A,G;C,G,A	269,1;272,1;273,1,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3646	porB1b	1041	1041	96.66	porB1b.l6.c4.ctg.1	1518	236.6	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	674	676	CAA	337;337;334	C;A,C;A,G	327;328,1;326,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3646	porB1b	1041	1041	96.66	porB1b.l6.c4.ctg.1	1518	236.6	0	.	p	.	0	M209I	NONSYN	625	627	ATG	872	874	ATC	335;334;333	A;T;C	326;312;321	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3646	porB1b	1041	1041	96.66	porB1b.l6.c4.ctg.1	1518	236.6	0	.	p	.	0	.	MULTIPLE	637	639	ACA	883	886	TCAG	309;312;312;310	T;C;A;G,A	297;302;303;302,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3646	porB1b	1041	1041	96.66	porB1b.l6.c4.ctg.1	1518	236.6	0	.	p	.	0	A240V	NONSYN	718	720	GCC	965	967	GTC	252;251;248	G;T,G;C	244;242,1;240	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3646	porB1b	1041	1041	96.66	porB1b.l6.c4.ctg.1	1518	236.6	0	.	p	.	0	G253Q	NONSYN	757	759	GGA	1004	1006	CAA	251;253;248	C;A;A	248;251;246	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3646	porB1b	1041	1041	96.66	porB1b.l6.c4.ctg.1	1518	236.6	0	.	p	.	0	.	INDELS	760	762	ACA	1008	1012	ATCAA	247;248;247;249;250	A;T;C;A;A	244;242;244;246;249	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3646	porB1b	1041	1041	96.66	porB1b.l6.c4.ctg.1	1518	236.6	0	.	p	.	0	.	INDELS	763	764	TG	1015	1017	AGT	252;253;254	A;G;T	248;251;252	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3646	porB1b	1041	1041	96.66	porB1b.l6.c4.ctg.1	1518	236.6	0	.	p	.	0	A257D	NONSYN	769	771	GCT	1022	1024	GAT	257;253;255	G;A;T	249;249;251	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3646	porB1b	1041	1041	96.66	porB1b.l6.c4.ctg.1	1518	236.6	0	.	p	.	0	V270A	NONSYN	808	810	GTA	1061	1063	GCG	291;291;296	G;C;G	285;285;289	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3646	porB1b	1041	1041	96.66	porB1b.l6.c4.ctg.1	1518	236.6	0	.	p	.	0	D293S	NONSYN	877	879	GAT	1130	1132	AGT	280;280;273	A;G;T	270;270;262	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3646	porB1b	1041	1041	96.66	porB1b.l6.c4.ctg.1	1518	236.6	0	.	p	.	0	N295D	NONSYN	883	885	AAC	1136	1138	GAC	267;266;268	G;A;C	262;257;261	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3646	porB1b	1041	1041	96.66	porB1b.l6.c4.ctg.1	1518	236.6	0	.	p	.	0	E326R	NONSYN	976	978	GAA	1229	1231	AGA	286;285;287	A;G;A	278;278;277	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	13046	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4794	269.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1596	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1083	145.3	1	SNP	p	V57M	1	.	.	169	171	ATG	505	507	ATG	330;331;324	A;T;G	323;322;317	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
